Results 101 to 110 of about 11,768 (183)

Heart and combined heart-liver transplantation in Asian patients with Fontan circulatory failure: a single-center experience. [PDF]

J Cardiothorac Surg
Shi C, Sun Y, Wang Z, Zhou C, Su W, Dong N, Shi J.   +6 more
europepmc   +1 more source

Changes in pharmacotherapy in adults with Fontan circulation and associations with outcomes. [PDF]

Int J Cardiol Congenit Heart Dis
Freddo AM, Eron M, Mondal A, Tomlinson AZ, Denduluri S, Farkas I, Partington S, Ruckdeschel E, Tsao AL, Mavroudis CD, Nuri M, Fuller S, Ortega-Legaspi JM, Kim YY, Vaikunth S.   +14 more
europepmc   +1 more source

Real-world experience with sodium-glucose cotransporter 2 inhibitors in adults with Fontan circulatory failure. [PDF]

Front Cardiovasc Med
Neijenhuis RML, Cedars AM, Zaidi A, Torres-Viera G, Mazurek R, Walker NL, Zemrak F, MacDonald ST, Hunter A, Kiès P, Bosch L, Swan L, van der Zwaan HB, Jukema JW, Jongbloed MRM, Veldtman GR, Egorova AD.   +16 more
europepmc   +1 more source

NT-proBNP and other blood biomarkers in patients after Fontan Surgery: Prognostic, diagnostic, and management implications. [PDF]

Int J Cardiol Congenit Heart Dis
Ahmed I, Gupta SK, Ramakrishnan L, Singh P, Das P.   +4 more
europepmc   +1 more source

Fontan Surgery in a Middle-Income Country: Outcomes and Modifiable Factors Potentially Associated with Risk - A 13-Year Single-Center Experience. [PDF]

Braz J Cardiovasc Surg
Santos RMD, Correia MG, Monteiro AJO, Canêo LF, Oliveira DM, Lamas CDC.   +5 more
europepmc   +1 more source

A Pilot Feasibility Study of Neurodevelopmental Surveillance After the Fontan Operation Using a Sedation-Free Brain MRI Approach. [PDF]

J Clin Med
Choi KH, Baek HJ, Kim H, Sung SC, Byun JH, Ko H, Lee HD, Yun RY, Kim JH, Skare S.   +9 more
europepmc   +1 more source

Direct assessment of total cavopulmonary connection power loss with interventional cardiac magnetic resonance in Fontan circulation. [PDF]

J Cardiovasc Magn Reson
Dahshi H, Hussain T, Veeram Reddy S, Arar Y, Gusseva M.   +4 more
europepmc   +1 more source

Reply: Fibrosis Is Inevitable, but Heterogeneous: Time-Dependent and Biochemical Modifiers of Liver Injury After Fontan Completion. [PDF]

JACC Adv
Rychik J.
europepmc   +1 more source

Extracardiac lateral tunnel Fontan: A better Fontan?

JTCVS Techniques
Harold M. Burkhart, Arshid Mir, Neil M. Venardos, Aswathy Vaikom House   +3 more
openaire   +2 more sources

Long-Term Outcomes of Antithrombotic Treatment in a Cohort of 864 Patients With Fontan Circulation. [PDF]

J Am Heart Assoc
Öztürk AG, Dellborg M, Damlin A, Giang KW, Mandalenakis Z, Sorensson P.   +5 more
europepmc   +1 more source